Videos

Sunil Rao, MD, FSCAI, 2022-23 President of the Society of Cardiovascular Angiography and Interventions (SCAI), and director of interventional cardiology NYU Langone, explains efforts by SCAI to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers (ASC).

Maintaining quality is key as more cardiac procedures migrate to outpatient ASCs

SCAI President Sunil Rao, MD, discussed the group's efforts to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers.

Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

SCAI President Sunil Rao, MD, explains the 2022-2023 SCAI accomplishments to improve interventional cardiology.

SCAI President Sunil Rao on how the society is helping advance interventional cardiology

Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

SCAI President Sunil Rao explains what he saw as the top 5 interventional studies at ACC23. #SCAI #ACC #ACC23

5 studies that could make a big impact on interventional cardiology

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

Echocardiography expert Patricia A. Pellikka, MD, discussed the trend of increasing artificial intelligence (AI) integration in cardiac ultrasound with Cardiovascular Business at American College of Cardiology (ACC) 2023 meeting.

AI's growing impact on echocardiography

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

Atul Verma explains thne results of the PULSE-AF trial at ACC23.

Pulsed-field ablation could be the next big EP technology trend

Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

ACC Vice President Cathie Biga discusses OBLs and ASCs during the ACC23 meeting. #ACC #OBLs #ASCs #ACC23

What the rise of outpatient cardiac OBLs and ASCs means for cardiology

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.

ACC Vice President Cathie Biga explains issues with cardiology reimbursements at ACC23. #ACC #ACC23

Reimbursement challenges raising concerns in cardiology

Cathie Biga, vice president of the American College of Cardiology, spoke to Cardiovascular Business at ACC.23 about challenges in the world of cardiology reimbursements. "As that healthcare dollar goes up, it is not going to the physicians," she said.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.